| General Information of Drug Metabolite (DM) (ID: DM018138) |
| DM Name |
ABT-418 Metabolite M1
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Aldehyde oxidase (AOX)
|
DME1092
|
| Oxidation - N'-oxidation |
ABT-418
|
[1] , [2] |
|
Cytochrome P450 (CYP)
|
DMEN060
|
| Oxidation - N'-oxidation |
ABT-418
|
[1] , [2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| ABT-418 |
DR3016
|
Discontinued in Phase 2 |
Alzheimer disease |
|
|
| References |
| 1 |
The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans
|
| 2 |
In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
